AI giant Anthropic creates drug research tool, plans its own studies for overlooked diseases

Anthropic, an AI company, has developed a drug research tool called Claude Science to accelerate scientific discovery and is launching its own preclinical drug programs for neglected diseases. The company aims to address diseases less profitable for pharmaceutical industries by leveraging its public-benefit status to balance profit with public good.